TOKYO, February 13, 2023 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) would like to express its deepest sympathy to victims of the earthquake in Turkey and Syria.

Astellas has pledged a donation as follows to support the victims and to assist in reconstruction efforts.

Contributor:    Astellas Pharma Inc. 
Donation to:    Japanese Red Cross Society
Amount:           JPY10,000,000

Astellas hopes for the earliest possible recovery in the affected areas.


Click below for a copy of the full press release


Contact the Media Relations team
Communications & Investor Relations
Main phone line for Media: +81-3244-3201 
Business hours (JST)
From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm
(closed on Saturdays, Sundays, national holidays and company holidays)